Shamez Ladhani to Neisseria meningitidis, Serogroup B
This is a "connection" page, showing publications Shamez Ladhani has written about Neisseria meningitidis, Serogroup B.
Connection Strength
2.618
-
Aseptic meningitis associated with routine infant immunisation visits that include the group B meningococcal vaccine, 4CMenB. Arch Dis Child. 2019 12; 104(12):1237-1238.
Score: 0.769
-
Meningococcal B Vaccine Failure With a Penicillin-Resistant Strain in a Young Adult on Long-Term Eculizumab. Pediatrics. 2017 Sep; 140(3).
Score: 0.669
-
Safety of meningococcal group B vaccination in hospitalised premature infants. Arch Dis Child Fetal Neonatal Ed. 2019 Mar; 104(2):F171-F175.
Score: 0.175
-
Growing evidence supports 4CMenB effectiveness. Lancet Infect Dis. 2018 04; 18(4):370-371.
Score: 0.172
-
Estimating primary care attendance rates for fever in infants after meningococcal B vaccination in England using national syndromic surveillance data. Vaccine. 2018 01 25; 36(4):565-571.
Score: 0.171
-
The yin and yang of fever after meningococcal B vaccination. Arch Dis Child. 2017 10; 102(10):881-882.
Score: 0.169
-
Frequent capsule switching in 'ultra-virulent' meningococci - Are we ready for a serogroup B ST-11 complex outbreak? J Infect. 2017 08; 75(2):95-103.
Score: 0.165
-
Short-term changes in the health state of children with group B meningococcal disease: A prospective, national cohort study. PLoS One. 2017; 12(5):e0177082.
Score: 0.165
-
Meningococcal serogroup B strain coverage of the multicomponent 4CMenB vaccine with corresponding regional distribution and clinical characteristics in England, Wales, and Northern Ireland, 2007-08 and 2014-15: a qualitative and quantitative assessment. Lancet Infect Dis. 2017 07; 17(7):754-762.
Score: 0.163